Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Multiplace Series
Hard-Shell Multiplace·2-18+ person
Pressure3 ATA
$150,000 - $400,000+
●●○○Emerging Evidence
Oxygen Therapy for Migraine & Cluster Headaches
100% oxygen is an established emergency treatment for cluster headache. HBOT adds pressure — with emerging evidence for chronic migraine prevention.
Hyperbaric oxygen therapy (HBOT) for Migraine & Cluster Headaches has emerging clinical evidence. This is currently an off-label use and is not covered by insurance. The recommended protocol is 1.0–1.5 ATA ATA for 45–90 minutes per session per session over 5–10 sessions (acute cluster abort); 20–40 sessions (preventive migraine) sessions.
Key Takeaways
- 100% oxygen at 1 ATA (normobaric) is a guideline-supported first-line treatment for acute cluster headache attacks
- Fogan (1985) RCT demonstrated O2 superiority over air for cluster headache abort
- Oxygen causes cerebrovascular vasoconstriction — the mechanism underlying both cluster and migraine benefit
- HBOT may offer preventive benefit for chronic migraine through repeated vasoregulation and neuroinflammation reduction
- CGRP and nitric oxide pathways targeted by oxygen overlap with modern migraine drug targets
What is Migraine & Cluster Headaches?
Oxygen therapy occupies a unique position in headache medicine: 100% oxygen delivered at normobaric pressure (1.0 ATA) is one of the only established, guideline-supported acute treatments for cluster headache attacks, backed by randomized controlled trial evidence and included in international headache society guidelines. This is distinct from hyperbaric oxygen therapy — the addition of pressure is what makes HBOT 'hyperbaric,' and that additional step has a smaller evidence base for headache specifically. For migraine, the evidence base is thinner and less consistent. Multiple case series and small trials have shown promise for HBOT in reducing migraine frequency and severity, but no large RCTs have confirmed these findings. The mechanism — oxygen as a potent vasoconstrictor — is well-established, but whether adding pressure provides meaningful additional benefit beyond normobaric oxygen for headache indications remains under investigation. It is important to understand the distinction: if your goal is aborting an active cluster headache, you need 100% oxygen delivered through a non-rebreather mask at high flow — not necessarily a hyperbaric chamber. If your interest is preventive treatment or migraine management, hyperbaric oxygen protocols are what you are looking for, and those have emerging but not definitive evidence.
How Hyperbaric Therapy Helps Migraine & Cluster Headaches
Oxygen is a powerful cerebrovascular vasoconstrictor — elevated blood oxygen levels cause blood vessels in the brain to narrow, which is therapeutic during a cluster or migraine attack where vessel dilation and inflammation are driving pain. At hyperbaric pressures, dissolved oxygen in plasma increases substantially, amplifying this vasoconstrictive effect. Additional mechanisms include: serotonin pathway modulation (relevant to migraine pathophysiology), trigeminal nerve calcitonin gene-related peptide (CGRP) suppression (the target of modern migraine drugs like gepants and CGRP antibodies), and nitric oxide regulation — nitric oxide is a potent vasodilator implicated in cluster headache pathophysiology. The combination of mechanical pressure, elevated oxygen tension, and these downstream signaling effects may explain why HBOT is explored for both acute cluster abort and preventive migraine management.
Recommended Protocol
Pressure
1.0–1.5 ATA
Sessions
5–10 sessions (acute cluster abort); 20–40 sessions (preventive migraine)
Duration
45–90 minutes per session
What Does the Evidence Say?
●●○○Emerging Evidence
For cluster headaches, Fogan (1985) published an RCT in Archives of Neurology showing 100% oxygen at 1 ATA significantly reduced attack severity compared to air — establishing the normobaric oxygen standard. The European Headache Federation and American Headache Society guidelines include high-flow 100% O2 as a first-line cluster headache acute treatment. For hyperbaric oxygen specifically in cluster headache, evidence is limited to case series. For migraine, multiple small studies have shown HBOT can reduce headache severity during attacks and decrease frequency with repeated sessions. A review published in Headache (2015) summarized the evidence as promising but insufficient for clinical guideline inclusion. The vasoconstriction mechanism is biologically sound, but larger RCTs are needed before HBOT can be recommended as standard care for migraine.
Off-Label Use
Migraine & Cluster Headaches is not an FDA-approved indication for HBOT. Treatment is considered off-label and is typically not covered by insurance. Consult your physician before starting any HBOT protocol.
Recommended Chambers for Migraine & Cluster Headaches
Based on the protocol requirements — minimum 1 ATA, Clinical Grade or Advanced Wellness tier. Sorted by clinical credibility score.
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 34
Hard-Shell Monoplace·1-person
Pressure3 ATA
$50,000 - $90,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 36
Hard-Shell Monoplace·1-person
Pressure3 ATA
$55,000 - $95,000
Clinical GradeFDA Cleared
For Maximum Comfort
Perry Baromedical
Sigma 40
Hard-Shell Monoplace·1-person
Pressure3 ATA
$65,000 - $110,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 40-II
Hard-Shell Multiplace·2-person
Pressure3 ATA
$100,000 - $160,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma Elite
Hard-Shell Monoplace·1-person
Pressure3 ATA
$80,000 - $130,000
Frequently Asked Questions
What is the difference between cluster headache oxygen treatment and HBOT?
Standard cluster headache treatment uses 100% oxygen delivered through a non-rebreather mask at normal atmospheric pressure (1.0 ATA, normobaric oxygen) — no pressurized chamber required. A flow rate of 12–15 L/min for 15–20 minutes aborts many cluster attacks. Hyperbaric oxygen therapy adds elevated pressure to this, increasing dissolved oxygen in the blood beyond what normobaric oxygen achieves. For acute cluster abort, normobaric oxygen is the established first-line approach. HBOT is investigated more for preventive protocols and for patients who don't respond to normobaric oxygen.
Can HBOT prevent migraines rather than just treat them acutely?
Preventive use is where HBOT research for migraine is most active. Repeated sessions appear to produce more durable changes in vascular reactivity, serotonin regulation, and neuroinflammation — potentially reducing migraine frequency over time. Case series have reported significant reductions in monthly migraine days after 20–40 HBOT sessions. However, no large RCT has been conducted specifically for migraine prevention with HBOT, so this remains off-label and experimental.
Will insurance cover HBOT for cluster headaches or migraine?
No. HBOT is not FDA-approved for headache indications, and neither normobaric nor hyperbaric oxygen therapy is covered by standard insurance for cluster headache or migraine (despite the clinical evidence for normobaric O2 in cluster headache). The 100% oxygen tank used for cluster abort is sometimes covered as durable medical equipment with a headache diagnosis. HBOT sessions at clinical facilities run $150–$350 per session out of pocket.
Can a soft-shell chamber help with migraines?
Soft-shell chambers operate at 1.3 ATA with ambient air (approximately 21% oxygen), not pure oxygen. The vasoconstriction mechanism that makes oxygen effective for headache specifically requires high oxygen tension — which requires either 100% O2 at 1 ATA or pressurized oxygen in a hard-shell chamber. A soft-shell chamber with ambient air will not replicate the oxygen levels studied in headache research. Some users report anecdotal relief from soft-shell chambers, but this is not backed by controlled trial evidence for headache indications.
Related Conditions
Sources & References
- Fogan (1985) — Treatment of Cluster Headache: A Double-Blind Comparison of Oxygen vs Air Inhalation, Archives of Neurology
- Rozen (2004) — High oxygen-flow therapy for cluster headache: a review, Headache
- Bennett et al. (2015) — Hyperbaric oxygen for migraine: a systematic review, Headache
- Cohen et al. (2009) — High-flow oxygen for treatment of cluster headache: A randomized trial, JAMA
Last updated: March 2026. Data sourced from manufacturer specifications, FDA databases, and published clinical research.
Ready to compare chambers?
Use our filterable directory to find chambers that match your protocol requirements.